Literature DB >> 11850538

Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands.

Michael Torbenson1, Susan C Abraham, John Boitnott, John H Yardley, Tsung-Teh Wu.   

Abstract

Autoimmune gastritis (AG) can be easily recognized when the histological features are fully developed, but recognizing AG before the complete loss of the oxyntic mucosa is more challenging. One feature of fully developed AG is enterochromaffin cell-like (ECL) hyperplasia, but its presence or absence in earlier stages of AG has not been fully evaluated. A retrospective study of biopsy specimens from 40 patients was performed; all of the patients were originally diagnosed with possible AG based on the presence of lymphocytic infiltration and damage to oxyntic glands and/or the presence of metaplastic epithelium that disproportionately involved the body mucosa. Nineteen cases had follow-up serological studies for anti-parietal cells and/or anti-intrinsic factor antibodies: 13 were positive and 6 negative. The remaining 21 cases were indeterminate because of incomplete testing. The histological findings were similar in the patients who were serologically positive and those who were indeterminate for AG. In all of these cases, the oxyntic mucosa showed lymphoplasmacytic infiltrates within the lamina propria with focal gland infiltration and damage. Sixty-five percent (22/34) of the cases showed intestinal and/or pyloric metaplasia, and 85% (29/34) showed parietal cell pseudohypertrophy. Chromogranin stains were performed in 11 of 13 cases with positive serological markers for AG, and all showed at least linear ECL cell hyperplasia. In contrast, none of the six cases with negative serological studies had linear ECL cell hyperplasia, P <.001. In conclusion, the following constellation of findings supports a diagnosis of AG before the complete loss of oxyntic mucosa: deep or diffuse lymphoplasmacytic infiltrates within the lamina propria with foci of gland infiltration and damage, epithelial metaplasia, parietal cell pseudohypertrophy, and ECL cell hyperplasia at the linear or greater level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850538     DOI: 10.1038/modpathol.3880499

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

1.  Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa?

Authors:  Klaus Dirschmid; Claudia Platz-Baudin; Manfred Stolte
Journal:  Virchows Arch       Date:  2005-09-28       Impact factor: 4.064

Review 2.  My approach to reporting a gastric biopsy.

Authors:  Carlos A Rubio
Journal:  J Clin Pathol       Date:  2006-09-08       Impact factor: 3.411

3.  The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.

Authors:  Jochen K M Lennerz; Seok-Hyung Kim; Edward L Oates; Won Jae Huh; Jason M Doherty; Xiaolin Tian; Andrew J Bredemeyer; James R Goldenring; Gregory Y Lauwers; Young-Kee Shin; Jason C Mills
Journal:  Am J Pathol       Date:  2010-08-13       Impact factor: 4.307

Review 4.  Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia.

Authors:  Gerhard Faller; Thomas Kirchner
Journal:  Virchows Arch       Date:  2004-12-04       Impact factor: 4.064

Review 5.  Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons.

Authors:  Gregory Y Lauwers; Hiroshi Fujita; Koji Nagata; Michio Shimizu
Journal:  J Gastroenterol       Date:  2009-12-05       Impact factor: 7.527

Review 6.  Autoimmune gastritis: Pathologist's viewpoint.

Authors:  Irene Coati; Matteo Fassan; Fabio Farinati; David Y Graham; Robert M Genta; Massimo Rugge
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 7.  Autoimmune atrophic gastritis--pathogenesis, pathology and management.

Authors:  William L Neumann; Elizabeth Coss; Massimo Rugge; Robert M Genta
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-18       Impact factor: 46.802

8.  Multiple gastric carcinoids associated with parietal cell hyperplasia: intraoperative detection with a radiolabeled somatostatin analog.

Authors:  Yoshinori Hosoya; Kiichi Satoh; Mitsugu Hironaka; Mitsuhiro Nokubi; Kentaro Kurashina; Chiaki Shibayama; Hideharu Sugimoto; Kentaro Sugano; Hideo Nagai; Yoshikazu Yasuda
Journal:  Gastric Cancer       Date:  2008-07-02       Impact factor: 7.370

Review 9.  The Natural Antimicrobial Enzyme Lysozyme is Up-Regulated in Gastrointestinal Inflammatory Conditions.

Authors:  Carlos A Rubio
Journal:  Pathogens       Date:  2014-01-16

Review 10.  Autoimmune atrophic gastritis: current perspectives.

Authors:  Artem Minalyan; Jihane N Benhammou; Aida Artashesyan; Michael S Lewis; Joseph R Pisegna
Journal:  Clin Exp Gastroenterol       Date:  2017-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.